Syndex Bio

Cambridge, United Kingdom

Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.

$15.5M raised

Feb 2026

Seed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Syndex Bio

How much funding has Syndex Bio raised?

Syndex Bio has raised $15.5M in total funding. The most recent round was Seed. The last funding was announced in February 2026.

Where is Syndex Bio headquartered?

Syndex Bio is headquartered in Cambridge, United Kingdom.

What does Syndex Bio do?

Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.

What stage is Syndex Bio at?

Syndex Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 23, 2026.

MLA

"Syndex Bio — Funding & Investors." VCBacked, February 23, 2026, https://www.vcbacked.co/company/syndex-bio. Accessed July 16, 2026.

APA

VCBacked. (2026). Syndex Bio — Funding & Investors. Retrieved July 16, 2026, from https://www.vcbacked.co/company/syndex-bio

Wikipedia (cite web)

{{cite web |title=Syndex Bio — Funding & Investors |url=https://www.vcbacked.co/company/syndex-bio |website=VCBacked |access-date=July 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 23, 2026.